0409-5093 : Tazicef 40 mg/ml Intravenous Injection, Powder, for Solution


NDC: 0409-5093
Labeler: Hospira, Inc.
Product Type: Human Prescription Drug
Drug Name:  Tazicef
Dosage Form: Intravenous Injection, Powder, for Solution
Application #: ANDA064032
Rev. Date: 


NDC Package Codes:

  • 0409-5093-11: 10 VIAL, PATENT DELIVERY SYSTEM IN 1 TRAY (0409‑5093‑11) > 50 ML IN 1 VIAL, PATENT DELIVERY SYSTEM
  • 0409-5093-51: 10 VIAL, PATENT DELIVERY SYSTEM IN 1 TRAY (0409‑5093‑51) > 50 ML IN 1 VIAL, PATENT DELIVERY SYSTEM

Active Ingredients:

  • Ceftazidime

Dosage Strength:

  • 2 g/1

Pharmaceutical Classes:

  • Cephalosporin Antibacterial [EPC]
  • Cephalosporins [CS]

Related Products:

Based on records with the same trade name.
  • 0409-5082 Tazicef 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Hospira, Inc.
  • 0409-5084 Tazicef 2 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Hospira, Inc.
  • 0409-5086 Tazicef 6 g/1 Intravenous Injection, Powder, for Solution by Hospira, Inc.
  • 0409-5092 Tazicef 20 mg/ml Intravenous Injection, Powder, for Solution by Hospira, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0409-5093 QR Code

< Prev: 0409-5092Next: 0409-5160 >

Related Discussions:

CEFTAZIDIME PRODUCT MONOGRAPH
PLEASE CEFTAZIDIME complete information as early as possible. ## Ceftazidime is usually reserved for the treatment of in... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.